Tag: SSRI

New research finds the negative drug effects most commonly associated with initiating antidepressant discontinuation are anxiety, suicidal thoughts, vomiting, and rashes.

New research finds that the non-physical aspects of withdrawal from SSRIs are often overlooked.

On the MIA Podcast, Dr David Healy discusses World Tapering Day, antidepressant treatment and sensory neuropathy and the difficulties that can be encountered when trying to deprescribe.

Anders Sørenson is a Danish clinical psychologist with a special interest in psychiatric drug withdrawal. He has undertaken research which assesses the state of guidance on psychiatric drug withdrawal and paid close attention to tapering methods with the aim of identifying approaches which might make withdrawal more tolerable for people.

We talk with author Beverley Thomson about her latest book, entitled Antidepressed: A Breakthrough Examination of Epidemic Antidepressant Harm and Dependence.

Patient advocates join with researchers and service users to present first-hand experiences of antidepressant withdrawal.

The promotion of SSRI antidepressant use began with the pharmaceutical industry and occurs despite evidence that these drugs are harmful, not helpful, in children and adolescents.

Our new discussion series aims to explore what we do and don’t know about safe withdrawal from antidepressants, antipsychotics, benzodiazepines and stimulants.

Noted antidepressant researcher, Michael Hengartner, summarizes the latest research on the use of antidepressants in children and adolescents.

Taking an SSRI antidepressant was associated with a 26% increased risk of violent crime conviction.

We interview Dr. Stuart Shipko, a psychiatrist and author who has a particular interest in the side effects and withdrawal effects of SSRI antidepressants and the need for informed consent when prescribing.

Slower tapering of antidepressant dose is generally more comfortable. However, success or failure after stopping completely mostly relates to whether tardive akathisia occurs.

Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.

“This is remarkable for drugs that are used to treat depressive symptoms,” write the researchers.

Researchers suggest that because most antidepressant “success” is due to the placebo effect, they may never find a way to predict outcomes.

Trials of antidepressants for relapse prevention are confounded by withdrawal effects caused by the drugs.

Study finds combining mirtazapine with an SSRI or SNRI is not clinically effective for improving depression in primary care patients who remained depressed after taking an SSRI or SNRI.

In the interest of the patients who are currently experiencing withdrawal reactions and the many more who will suffer withdrawal effects in the future, we need to end this “war.” Academic psychiatry must address these problems and conduct thorough research on withdrawal reactions.

Alterations in gray matter and white matter development found in infants of mothers taking SSRI antidepressants during pregnancy.

Doctoral candidate Akansha Vaswani interviews researcher and geneticist Dr. Peter Groot, who has led the development of Tapering Strips, a novel and practical method by which people taking certain prescription medications can gradually reduce their dosage.

On June 19th, Joanna Moncrieff and Carmine Pariante held an online antidepressant Q&A session with host Danny Whittaker. There was an initial debate, followed...

Effects of discontinuing SSRIs and SNRIs reported on an online forum indicate significant and long-lasting withdrawal symptoms.

The Royal Australian and New Zealand College of Psychiatrists claimed that “the prescription of antidepressant or antipsychotic medications is something that a psychiatrist only ever does in partnership with the patient and after due consideration of the risks and benefits.” How could a responsible professional body make an assertion so patently wrong?

Psychiatrist Dr Allen Frances argues when people face "mild, transient depression," antidepressants shouldn't become "a way of treating the aches and pains of everyday life."

After a meta-analysis of RCTs of antidepressants was published in Lancet, psychiatry stated that it proved that "antidepressants" work. However, effectiveness studies of real-world patients reveal the opposite: the medications increase the likelihood that patients will become chronically depressed, and disabled by the disorder.